REFERENCES
- Baselga E, Drolet BA, Esterly NB. Purpura in infants and children. J Am Acad Dermatol. 1997;37:673–705.
- Suvatte V, Mahasandana C, Tanphaichitr V, Tuchinda S. Acquired platelet dysfunction with eosinophilia: study of platelet function in 62 cases. Southeast Asian J Trop Med Public Health. 1979;10:358–367.
- Laosombat V, Wongchanchailert M, Sattayasevana B, Acquired platelet dysfunction with eosinophilia in children in the south of Thailand. Platelets. 2001;12:5–14.
- Monterrubio Villar J, Córdoba López A, Macayo Sánchez AJ. Idiopathic eosinophilia associated with portal vein and massive thrombosis: successful thrombolysis with streptokinase. Med Sci Monit. 2006;12:CS53–CS56.
- Ohguchi H, Sugawara T, Harigae H. Thrombotic thrombocytopenic purpura complicated with hypereosinophilic syndrome. Intern Med. 2009;48:1687–1690.
- Petrini P. Treatment strategies in children with hemophilia. Paediatr Drugs. 2002;4:427–437.
- Schaub RG. Recent advances in the development of coagulation factors and procoagulants for the treatment of hemophilia. Biochem Pharmacol. 2011;82:91–98.
- Hoffman M. Remodeling the blood coagulation cascade. J Thromb Thrombol. 2003;16:17–20.
- Hoffman MM, Monroe DM. Rethinking the coagulation cascade. Curr Hematol Rep. 2005;4:391–396.
- Pouplard C, Trossaert M, LE Querrec A, Influence of source of phospholipids for APTT-based factor IX assays and potential consequences for the diagnosis of mild haemophilia B. Haemophilia. 2009;15:365–368.
- Park CH, Seo JY, Kim HJ, A diagnostic challenge: mild hemophilia B with normal activated partial thromboplastin time. Blood Coagul Fibrinol. 2010;21:368–371.
- Plug I, Mauser-Bunschoten EP, Bröcker-Vriends AH, Bleeding in carriers of hemophilia. Blood. 2006;108:52–56.
- Nash TE. Human case management and treatment of cysticercosis. Acta Trop. 2003;87:61–69.
- Singh G, Murthy JM. Solitary cysticercus granuloma-treatment with albendazole: what is the optimal duration? Neurol India. 2010;58:507–508.